16/10/2020
Introducing Sugammadex Sodium made by Medichem
Sugammadex Sodium is an injectable solution indicated for the reversal of neuromuscular blockade in anesthesia. Medichem is a vertically ...
07/07/2020
A Policy Roadmap for Medicines Manufacturing Leadership
As part of our work with @Medicines for Europe, we have developed a policy roadmap for medicines manufacturing in Europe. The #COVID19 crisis has ...
22/05/2020
ASIA Q1´20 – Latest Authorizations
Medichem´s DMFs for the Active Pharmaceutical Ingredient of Paroxetine and Rivaroxaban are filed and listed on the CDE website, China – Q...
14/03/2020
Corporate Announcement 14.03.2020
Dear Customer, Like many of you we have been closely following the developments about coronavirus. At Medichem we deeply care about our ...
20/01/2020
Q4’19 – Latest Authorizations by the Regulatory Agencies – Asia
Medichem receives the Approval Notice Letter by the Korean Authorities for Apixaban´s Active Pharmaceutical Ingredient – Q4’19 Mediche...
12/07/2019
Medichem’s R&D and Business Development summit in ESADECREAPOLIS
What could be more inspiring than the ESADECREAPOLIS meeting rooms for Medichem's R&D and Business Development summit? On July 9th and 10th,...
05/07/2019
USP’s Donor Recognition Program would like to recognize Medichem for its contributions…
"USP’s Donor Recognition Program would like to recognize Medichem for its contributions during the 2018 calendar year" Says Ronald T. Pie...
05/07/2019
“Fostering The Culture of Innovation and Excellence”
On June 26th, Medichem participated in a Design Thinking Workshop organized by Ship2B. In line with Medichem´s Culture of Innovation, th...
30/04/2019
We are proud to announce that Medichem´s Rivaroxaban 2.5mg, 10mg, 15mg and 20 mg DCP has been approved! … And API Rivaroxaban EU and US DMFs have been successfully filed!
29/11/2018
Ampliación de la Capacidad Productiva / Production Capacity Expansion
Medichem has carried out a project from 2016- till 2017 to expand the production capacity of its plant in Celrà, which has been fina...
15/02/2018
CDTI
Durante los años 2015-2017 el proyecto de Medichem ANTAGONISTA DE LA RELAJACIÓN MUSCULAR ha sido cofinanciado por el Fondo Europeo de Desarrollo Re...
27/04/2017
Combino Pharm’s solid oral dosage forms plant in Malta passes US FDA inspection
A favorable US FDA inspection at Medichem’s subsidiary Combino Pharm’s plant in Malta opens the door to the commercialization of solid or...
15/03/2016
Medichem launches Award in Organic Chemistry
We are proud to announce that Medichem Manufacturing (Malta) Ltd. has been one of sponsors of this year's annual National Chemistry Symposium, orga...
04/05/2015
FDA inspection in Celrà (Spain) with no “Form 483” for the sixth consecutive time
The latest US FDA inspection of our plant in Celrà (Girona), Spain in April resulted in no “Form 483” (no observations were noted). For the Celrà s...
03/03/2015
Medichem: Launch of our new website
We are happy to announce the launch of our Medichem’s new website which uses our new corporate identity.
03/03/2015
DO YOU KNOW WHAT FLOW CHEMISTRY IS?
Flow Chemistry is a technique involving the use of structured devices, also called microreactor or flow reactors, where reactants are combined and ...
03/03/2015
DID YOU KNOW THAT CHLORHEXIDINE DIGLUCONATE IN ORAL CARE…?
FACTS ABOUT CHLORHEXIDINE IN ORAL CARE Chlorhexidine is an antiseptic and antimicrobial often used as an active ingredient in oral rinse. ...
03/02/2015
FDA inspection in Hal Far (Malta) with no “Form 483” for the second consecutive time
Medichem Malta plant passed a US FDA inspection for the second consecutive time without receiving any observation. The inspection of Medichem’s pl...
11/05/2014
Installation of Continuous Flow reactor at industrial scale in our plant in Spain
03/05/2014
Start operations of High Potency API plant in Malta
In May 2014, Medichem opened a brand new High Potency API unit (HPAPI) in its Maltese plant, located in Hal Far. The HPAPI modular laboratory is a ...
03/09/2012
FDA inspection in Celrà (Spain) with no “Form 483” for the fifth consecutive time
The latest FDA inspection of our plant in Celrà (Girona), Spain in September resulted in no “Form 483” (no observations were noted). The inspectio...
03/08/2012
Set up of Nanjing Medichem Biopharmaceutical Development Co. Ltd, our R&D Center in Nanjing, China
03/04/2012
FDA inspection in Hal Far (Malta) with no “Form 483”
The latest FDA inspection of our plant in Hal Far (Malta) in April resulted in no “Form 483” (no observations were noted). Times of Malta
03/03/2012
40th anniversary of the foundation of the company
This year, we celebrate our 40th anniversary in the global pharmaceutical industry. During these 40 years, our goal has always been constant innov...
03/04/2009
FDA inspection in Celrà with no form-483 for the fourth consecutive time
The latest FDA inspection of our Spanish plant in Celrà (Girona) in April resulted in no form 483 (no observations were noted) for the fourth conse...
03/12/2007
Plant in Malta inspected by the FDA
The Malta plant in Hal Far, which started operations in November 2005, received FDA inspection in December 2007
03/11/2006
FDA inspection in Celrà with no form-483 for the third consecutive time
The latest FDA inspection of our plant in Celrà in Spain conducted in November resulted in no form 483 (no observations were noted) for the third c...
03/11/2005
New production plant in Malta
Medichem inaugurated its new production plant in Hal Far in Malta in November 2005. The plant is equipped with the state-of-the-art equipment and ...
03/11/2005
November 2005 – Visit of President of Malta to our plant in Celrà
On 10th November His Excellency Dr. Edward Fenech-Adami, President of Malta, paid a visit to our facilities in Celrà, Spain. President Fenech Adami...
03/04/2002
FDA inspection in Celrà with no form-483
Since 1985 our plant in Celrà in the province of Girona in Spain has been regularly inspected and found acceptable by the FDA. For the second cons...
post of